News | ECMO Systems | February 22, 2018

New Protocol Gives Patients Fighting Chance to Survive Cardiac Arrest

ECMO-based protocol improves sudden cardiac arrest survival from 0 to 40 percent

New Protocol Gives Patients Fighting Chance to Survive Cardiac Arrest

February 22, 2018 — When someone goes into cardiac arrest and first responders cannot shock their heart back into rhythm, there is virtually no chance of survival. However, a new protocol being tested at The Ohio State University Wexner Medical Center is already saving lives – increasing survival rates from zero to about 40 percent.

“It’s astounding that patients are able to fully recover and walk out of the hospital when they would have been pronounced dead in the field before this protocol was in place,” said K. Dean Boudoulas, M.D., a cardiologist and assistant professor of internal medicine at The Ohio State University Wexner Medical Center.

The extracorporeal cardiopulmonary resuscitation (ECPR) protocol was developed through a partnership with the Columbus Division of Fire. It is initiated by EMS if they are not able to restore normal rhythm after shocking a patient’s heart three times. After alerting the hospital, emergency personnel connect the patient to a device that automatically delivers CPR to preserve the patient’s brain and organ function on the way to the hospital. Upon arrival, the patient bypasses the emergency room and is taken straight to the heart catheterization lab where they are connected to an extracorporeal membrane oxygenation (ECMO) machine.

“This allows the heart and lungs to rest while doctors perform a heart catheterization to find the problem, which is usually a blocked artery,” said Bryan Whitson, M.D., Ph.D., director of the Collaboration for Organ Perfusion, Protection, Engineering and Regeneration at Ohio State.

With positive results from this and other pilot studies, experts hope that the protocol will become standard care in treating cardiac arrests.

Watch the VIDEO: Ohio State University Introduces ECMO Protocol for Cardiac Arrest

For more information: www.wexnermedical.osu.edu

 

Related Content

New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Mobility May Predict Elderly Heart Attack Survivors' Repeat Hospital Stays
News | Cath Lab | April 23, 2019
Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may...
FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Overlay Init